Cargando…
Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis
IgA vasculitis (IgAV), formerly known as Henoch-Schönlein purpura, is the most common cause of systemic vasculitis in childhood. Given its potential life-threatening systemic complications, early and accurate diagnosis as well as management of IgAV represent a major challenge for health care profess...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669874/ https://www.ncbi.nlm.nih.gov/pubmed/34917176 http://dx.doi.org/10.1177/1759720X211059610 |
_version_ | 1784614867193298944 |
---|---|
author | Abu-Zaid, Mohammed Hassan Salah, Samia Lotfy, Hala M. El Gaafary, Maha Abdulhady, Hala Tabra, Samar abd Alhamed Salah, Hala Farag, Yomna Eissa, Mervat Maher, Sheren Esam Radwan, Ahmed El-Shanawany, Amira Tarek Medhat, Basma M. El Mikkawy, Dalia Mosad Mosa, Doaa El Deriny, Ghada Mortada, Mohamed Osman, Naglaa S. Fouad, Nermeen Ahmed Elkaraly, Nourhan Elameen Mohamed, Sally S. Hassan, Waleed A. Amer, Youmna A. Nasef, Samah Ismail El Miedany, Yasser |
author_facet | Abu-Zaid, Mohammed Hassan Salah, Samia Lotfy, Hala M. El Gaafary, Maha Abdulhady, Hala Tabra, Samar abd Alhamed Salah, Hala Farag, Yomna Eissa, Mervat Maher, Sheren Esam Radwan, Ahmed El-Shanawany, Amira Tarek Medhat, Basma M. El Mikkawy, Dalia Mosad Mosa, Doaa El Deriny, Ghada Mortada, Mohamed Osman, Naglaa S. Fouad, Nermeen Ahmed Elkaraly, Nourhan Elameen Mohamed, Sally S. Hassan, Waleed A. Amer, Youmna A. Nasef, Samah Ismail El Miedany, Yasser |
author_sort | Abu-Zaid, Mohammed Hassan |
collection | PubMed |
description | IgA vasculitis (IgAV), formerly known as Henoch-Schönlein purpura, is the most common cause of systemic vasculitis in childhood. Given its potential life-threatening systemic complications, early and accurate diagnosis as well as management of IgAV represent a major challenge for health care professionals. This study was carried out to attain an evidence-based expert consensus on a treat-to-target management approach for IgAV using Delphi technique. The preliminary scientific committee identified a total of 16 key clinical questions according to the patient, intervention, comparison, and outcomes (PICO) approach. An evidence-based, systematic, literature review was conducted to compile evidence for the IgAV management. The core leadership team identified researchers and clinicians with expertise in IgAV management in Egypt upon which experts were gathered from different governorates and health centers across Egypt. Delphi process was implemented (two rounds) to reach a consensus. An online questionnaire was sent to expert panel (n = 26) who participated in the two rounds. After completing round 2, a total of 20 recommendation items, categorized into two sections were obtained. Agreement with the recommendations (rank 7–9) ranged from 91.7–100%. Consensus was reached (i.e. ⩾75% of respondents strongly agreed or agreed) on the wording of all the 20 clinical standards identified by the scientific committee. Algorithms for the diagnosis and management have been suggested. This was an expert, consensus recommendations for the diagnosis and treatment of IgAV and IgA vasculitic nephritis, based on best available evidence and expert opinion. The guideline presented a strategy of care with a pathway to achieve a state of remission as early as possible. PLAIN LANGUAGE SUMMARY: Given its potential life-threatening systemic complications, early and accurate diagnosis of immunoglobulin A vasculitis represents a major challenge for health care professionals. This work provided cornerstone principles for the management of the condition. Adopting PICO approach and implementing Delphi process a consensus was reached on evidence-based treat-to-target treatment recommendations. This will endorse enhancement and consistency of care of this cohort of patients in standard practice. |
format | Online Article Text |
id | pubmed-8669874 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-86698742021-12-15 Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis Abu-Zaid, Mohammed Hassan Salah, Samia Lotfy, Hala M. El Gaafary, Maha Abdulhady, Hala Tabra, Samar abd Alhamed Salah, Hala Farag, Yomna Eissa, Mervat Maher, Sheren Esam Radwan, Ahmed El-Shanawany, Amira Tarek Medhat, Basma M. El Mikkawy, Dalia Mosad Mosa, Doaa El Deriny, Ghada Mortada, Mohamed Osman, Naglaa S. Fouad, Nermeen Ahmed Elkaraly, Nourhan Elameen Mohamed, Sally S. Hassan, Waleed A. Amer, Youmna A. Nasef, Samah Ismail El Miedany, Yasser Ther Adv Musculoskelet Dis Review IgA vasculitis (IgAV), formerly known as Henoch-Schönlein purpura, is the most common cause of systemic vasculitis in childhood. Given its potential life-threatening systemic complications, early and accurate diagnosis as well as management of IgAV represent a major challenge for health care professionals. This study was carried out to attain an evidence-based expert consensus on a treat-to-target management approach for IgAV using Delphi technique. The preliminary scientific committee identified a total of 16 key clinical questions according to the patient, intervention, comparison, and outcomes (PICO) approach. An evidence-based, systematic, literature review was conducted to compile evidence for the IgAV management. The core leadership team identified researchers and clinicians with expertise in IgAV management in Egypt upon which experts were gathered from different governorates and health centers across Egypt. Delphi process was implemented (two rounds) to reach a consensus. An online questionnaire was sent to expert panel (n = 26) who participated in the two rounds. After completing round 2, a total of 20 recommendation items, categorized into two sections were obtained. Agreement with the recommendations (rank 7–9) ranged from 91.7–100%. Consensus was reached (i.e. ⩾75% of respondents strongly agreed or agreed) on the wording of all the 20 clinical standards identified by the scientific committee. Algorithms for the diagnosis and management have been suggested. This was an expert, consensus recommendations for the diagnosis and treatment of IgAV and IgA vasculitic nephritis, based on best available evidence and expert opinion. The guideline presented a strategy of care with a pathway to achieve a state of remission as early as possible. PLAIN LANGUAGE SUMMARY: Given its potential life-threatening systemic complications, early and accurate diagnosis of immunoglobulin A vasculitis represents a major challenge for health care professionals. This work provided cornerstone principles for the management of the condition. Adopting PICO approach and implementing Delphi process a consensus was reached on evidence-based treat-to-target treatment recommendations. This will endorse enhancement and consistency of care of this cohort of patients in standard practice. SAGE Publications 2021-12-09 /pmc/articles/PMC8669874/ /pubmed/34917176 http://dx.doi.org/10.1177/1759720X211059610 Text en © The Author(s), 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Review Abu-Zaid, Mohammed Hassan Salah, Samia Lotfy, Hala M. El Gaafary, Maha Abdulhady, Hala Tabra, Samar abd Alhamed Salah, Hala Farag, Yomna Eissa, Mervat Maher, Sheren Esam Radwan, Ahmed El-Shanawany, Amira Tarek Medhat, Basma M. El Mikkawy, Dalia Mosad Mosa, Doaa El Deriny, Ghada Mortada, Mohamed Osman, Naglaa S. Fouad, Nermeen Ahmed Elkaraly, Nourhan Elameen Mohamed, Sally S. Hassan, Waleed A. Amer, Youmna A. Nasef, Samah Ismail El Miedany, Yasser Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis |
title | Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis |
title_full | Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis |
title_fullStr | Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis |
title_full_unstemmed | Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis |
title_short | Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis |
title_sort | consensus evidence-based recommendations for treat-to-target management of immunoglobulin a vasculitis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669874/ https://www.ncbi.nlm.nih.gov/pubmed/34917176 http://dx.doi.org/10.1177/1759720X211059610 |
work_keys_str_mv | AT abuzaidmohammedhassan consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT salahsamia consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT lotfyhalam consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT elgaafarymaha consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT abdulhadyhala consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT tabrasamarabdalhamed consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT salahhala consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT faragyomna consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT eissamervat consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT mahersherenesam consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT radwanahmed consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT elshanawanyamiratarek consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT medhatbasmam consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT elmikkawydalia consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT mosadmosadoaa consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT elderinyghada consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT mortadamohamed consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT osmannaglaas consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT fouadnermeenahmed consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT elkaralynourhanelameen consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT mohamedsallys consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT hassanwaleeda consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT ameryoumnaa consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT nasefsamahismail consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis AT elmiedanyyasser consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis |